Discriminative stimulus effects of dopaminergic agents in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 2, 1996, Pages 517-523

  Koetzner, Lee ^a,b   Riley, Anthony L ^b   Glowa, John R ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b AMERICAN UNIVERSITY   (United States)

Author keywords

Cocaine; d Amphetamine; Drug abuse; Drug discrimination; GBR 12909; Phentermine; Rhesus monkeys

Indexed keywords

BUSPIRONE; COCAINE; DEXAMPHETAMINE; PHENTERMINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EFFECT; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALIA; MACACA MULATTA;

EID: 0029891831     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02282-1     Document Type: Article

References (31)

1. Andersen, P. H. The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:493-504; 1989.
2. Ator, N. A.; Griffiths, R. R. Differential sensitivity to midazolam discriminative-stimulus effects following self-administered vs. response-independent midazolam. Psychopharmacology (Berlin) 110:1-4; 1993.
3. 3 antagonists and benzodiazepines (their comparative behavioral pharmacology). Chichester, UK: John Wiley; 1991:59-105.
4. Caine, S. B.; Koob, G. F. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6:333-347; 1995.
5. Cunningham, K. A.; Callahan, P. M. Monoamine uptake inhibitors enhance the discriminative state induced by cocaine in rats. Psychopharmacology (Berlin) 104:177-180; 1991.
6. DeLean, A.; Munson, P. J.; Rodbard, D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235:E97-E102; 1978.
7. Gawin, F. H. Chronic neuropharmacology of cocaine: Progress in pharmacotherapy. J. Clin. Psychiatry Suppl. 49:11-16; 1988.
8. Glowa, J. R.; Wojnicki, F. H. E.; Matecka, D.; Bacher, J.; Mansbach, R. S.; Balster, R. L.; Rice, K. C. Effects of dopamine reuptake inhibitors on food and cocaine maintained responding. I: Dependence on unit dose of cocaine. Exp. Clin. Psychopharmacol. 3:219-231; 1995.
9. Glowa, J. R.; Wojnicki, F. H. E.; Matecka, D.; Rice, K.; Rothman, R. B. Effects of dopamine reuptake inhibitors on food and cocaine maintained responding. II: Comparisons with other drugs and repeated administrations. Exp. Clin. Psychopharmacol. 3: 232-239; 1995.
10. Glowa, J. R.; Wojnicki, F. H. E.; Rothman, R. B. Effects of phentermine, fenfluramine and both in combination on food- and cocaine-maintained responding of rhesus monkeys. Soc. Neurosci. Abstr. 20:222; 1994.
11. Glowa, J. R.; Wojnicki, F. H. E. Effects of dopamine modulators on food and cocaine maintained responding. III: Comparisons of effects of dopamine antagonists using different unit doses of cocaine (submitted).
12. Hitzig, P. Combined dopamine and serotonin agonists: A synergistic approach. Maryland Med. J. 42:153-156; 1993.
13. Hoffman, B. B.; Lefkowitz, R. J. Catecholamines and sympathomimetic drugs. In: Gilman, A. G.; Rall, T. W.; Nies, A. S.; Taylor, P., eds. Goodman and Gilman's the pharmacological basis of therapeutics (8th ed.) New York: Pergamon; 1990:187-220.
14. Howell, L.; Byrd, L. D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmacol. Exp. Ther. 258:178-185; 1991.
15. Jaffe, J. H. Drug addiction and drug abuse. In: Gilman, A. G.; Rall, T. W.; Nies, A. S.; Taylor, P., eds. Goodman and Gilman's the pharmacological basis of therapeutics (8th ed.) New York: Pergamon; 1990:522-573.
16. Johnson, D. N.; Vocci, F. J. Medications development at the National Institute on Drug Abuse: Focus on cocaine. In: Cocaine treatment: Research and clinical perspectives. NIDA Research Monograph Series, No. 135. U.S. Dept. Health & Human Services, NIH Publication No. 93-3639:57-70; 1993.
17. Kleven, M. S.; Anthony, E. W.; Woolverton, W. L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:312-317; 1990.
18. Koetzner, L.; Mastropaolo, J.; Deutsch, S. I. Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination. Pharmacol. Biochem. Behav. 52:815-818.
19. Koob, G. F.; Weiss, F. Pharmacology of drug self-administration. Alcohol 7:193-197; 1990.
20. Melia, K. F.; Spealman, R. D. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J. Pharmacol. Exp. Ther. 258:626-632; 1991.
21. Overton, D. A. Applications and limitations of the drug discrimination method for the study of drug abuse. In: Bozarth, M. A., ed. Methods of assessing the reinforcing properties of abused drugs. New York: Springer-Verlag; 1987:291-340.
22. Parsons, L. H.; Justice, J. B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:195-199; 1993.
23. Rapoza, D. Buspirone fails to affect the discriminative stimulus effects of cocaine. Pharmacol. Biochem. Behav. 45:179-183; 1993.
24. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223; 1987.
25. Rothman, R. B. High affinity dopamine reuptake blockers as potential cocaine antagonists: A strategy for drug development. Life Sci. 46:PL17-PL21; 1990.
26. Rothman, R. B.; Glowa, J. R. A review of the effects of dopaminergic agents on humans, animals and drug-seeking behavior, and its implications for medication development: Focus on GBR 12909. Mol. Neurobiol. 10:1-19; 1995.
27. Rothman, R. B.; Mele, A.; Reid, A.; Akunne, H.; Greig, N.; Thurkauf, A.; de Costa, B.; Rice, K. C.; Pert, A. GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40:387-397; 1991.
28. Spealman, R. D. Use of cocaine-discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. In: Harris, L. S., ed. Problems of drug dependence. NIDA Monograph 119. Washington, DC: U.S. GPO; 1991:175-179.
29. van der Zee, P.; Koger, H. S.; Gootjes, J.; Hespe, W. Aryl 1,4-dialk(en)yl-piperaziones as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:363-370; 1980.
30. Wojnicki, F. H. E.; Bacher, J. D.; Glowa, J. R. The use of SC vascular access port in rhesus monkeys. Lab. Anim. Med. 44: 491-494; 1994.
31. Wood, D. M.; Emmett-Oglesby, M. W. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacology (Berlin) 95:364-368; 1988.